For most organizations, honest answers to these questions lead to the same conclusion: Buy a sound foundation and innovate on ...
Veeva Systems (NYSE:VEEV) serves the life sciences software sector with products designed for pharmaceutical and biotechnology organizations. Recent developments highlight a stronger shift toward its ...
With broad industry success and the availability of Veeva AI, Vault CRM is the leader in agentic CRM for life sciences PLEASANTON, Calif., March 3, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ...
CEO Peter Gassner stated, "We had a strong finish to the year, delivering results ahead of our guidance. Total revenue in the quarter was $836 million with non-GAAP operating income of $366 million.
With broad industry success and the availability of Veeva AI, Vault CRM is the leader in agentic CRM for life sciences The strong momentum behind Vault CRM reflects the clear business value of its ...
Investing.com - Stifel raised its price target on Veeva Systems shares (NYSE:VEEV) to $245 from $212 while maintaining a Buy rating. This target aligns closely with InvestingPro’s Fair Value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results